SYNH
Syneos Health Inc
A biopharmaceutical services company that helps drugmakers and biotech firms run clinical trials and get new medicines to market. Born in 2018 from the merger of clinical-research firm INC Research and commercialization specialist inVentiv Health, it manages everything from early-stage testing to marketing new drugs. Its name blends "syn" for synchronizing clinical and commercial work with "neo" for a new approach — and its HQ in Raleigh, North Carolina, now serves clients across dozens of countries.
CUSIP: 87166B102HealthcareUS4 holders
Total Value
$193.24M
Total Shares
4.59M
Net Share Change
+4.43M
Activity
3 buying
Investor
Value
Shares
Weight
Change
